UiPath Inc. (NYSE:PATH) Shares Purchased by Treasurer of the State of North Carolina

Treasurer of the State of North Carolina grew its stake in shares of UiPath Inc. (NYSE:PATHFree Report) by 2.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 168,768 shares of the healthcare company’s stock after acquiring an additional 3,780 shares during the period. Treasurer of the State of North Carolina’s holdings in UiPath were worth $4,192,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Artisan Partners Limited Partnership purchased a new stake in UiPath during the fourth quarter valued at about $48,267,000. Hsbc Holdings PLC lifted its holdings in shares of UiPath by 14.8% in the fourth quarter. Hsbc Holdings PLC now owns 98,725 shares of the healthcare company’s stock valued at $2,455,000 after purchasing an additional 12,691 shares in the last quarter. Intech Investment Management LLC boosted its position in shares of UiPath by 3.1% in the fourth quarter. Intech Investment Management LLC now owns 14,324 shares of the healthcare company’s stock worth $356,000 after buying an additional 426 shares during the period. Nomura Asset Management Co. Ltd. grew its holdings in shares of UiPath by 18.0% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 100,500 shares of the healthcare company’s stock valued at $2,496,000 after buying an additional 15,300 shares in the last quarter. Finally, Neuberger Berman Group LLC grew its holdings in shares of UiPath by 38.4% during the fourth quarter. Neuberger Berman Group LLC now owns 20,133 shares of the healthcare company’s stock valued at $500,000 after buying an additional 5,586 shares in the last quarter. 62.50% of the stock is owned by institutional investors.

UiPath Trading Down 2.8 %

Shares of PATH opened at $11.92 on Tuesday. UiPath Inc. has a one year low of $11.53 and a one year high of $27.87. The company’s fifty day moving average price is $19.70 and its 200 day moving average price is $22.04.

UiPath (NYSE:PATHGet Free Report) last issued its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.10. UiPath had a negative return on equity of 2.99% and a negative net margin of 6.41%. The company had revenue of $405.25 million for the quarter, compared to the consensus estimate of $383.32 million. As a group, equities analysts predict that UiPath Inc. will post -0.04 EPS for the current year.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 16,000 shares of the firm’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $22.84, for a total value of $365,440.00. Following the sale, the chief financial officer now owns 87,505 shares in the company, valued at $1,998,614.20. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders sold a total of 96,000 shares of company stock worth $2,023,440 over the last three months. 22.37% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on PATH shares. JPMorgan Chase & Co. decreased their price objective on UiPath from $28.00 to $19.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Bank of America restated a “neutral” rating and set a $16.00 price target (down from $30.00) on shares of UiPath in a report on Thursday, May 30th. KeyCorp reiterated a “sector weight” rating on shares of UiPath in a research note on Thursday, May 30th. Truist Financial reissued a “hold” rating and set a $14.00 target price (down previously from $32.00) on shares of UiPath in a research note on Thursday, May 30th. Finally, Morgan Stanley dropped their price target on shares of UiPath from $25.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 30th. Sixteen investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $18.12.

Get Our Latest Research Report on UiPath

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.